Showing 2711-2720 of 3742 results for "".
Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.A Nose for Disease: A Review of Olfactory-Based Diagnosis in Dermatology
https://practicaldermatology.com/topics/infections-infectious-disease/a-nose-for-disease-a-review-of-olfactory-based-diagnosis-in-dermatology/23650/Despite technological advancements in diagnosis, the sense of smell can still be a helpful tool in the medical clinic.Emerging Business Concept: The Acne Treatment Center
https://practicaldermatology.com/topics/practice-management/emerging-business-concept-the-acne-treatment-center/20700/What if there was a practice devoted solely to the treatment of acne and acne scars?Mycosis Fungoides: Practical Tips on Specific Therapies
https://practicaldermatology.com/topics/general-topics/mycosis-fungoides-practical-tips-on-specific-therapies/21973/With common sense and knowledge of the therapy being administered, the dermatologist can effectively and safely treat MF patients.Are We All Clear?
https://practicaldermatology.com/topics/psoriasis/are-we-all-clear/20725/Understanding the safety of biologics for psoriasis in real-world settings.The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.Emerging Therapies in the Evolving Biologic Platform for Psoriasis Treatment
https://practicaldermatology.com/topics/practice-management/emerging-therapies-in-the-evolving-biologic-platform-for-psoriasis-treatment/21377/Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Staphylococcus aureus and Atopic Dermatitis: Unweaving a Tangled Web
https://practicaldermatology.com/topics/general-topics/staphylococcus-aureus-and-atopic-dermatitis-unweaving-a-tangled-web/22083/Though the relationship is not fully understood, it points the way to potential treatments.The Hidradenitis Suppurativa Therapeutic Pipeline
https://practicaldermatology.com/topics/rare-disease/the-hidradenitis-suppurativa-therapeutic-pipeline/54824/Though treatment options are currently limited, the pipeline for HS therapeutics is active with numerous medications in development.